C14orf105 | Chromosome 14 open reading frame 105 | | | | | | Group enriched |
CDH9 | Cadherin 9, type 2 (T1-cadherin) | Predicted membrane proteins
| | | | | Group enriched |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like | Transcription factors
| | | | | Group enriched |
C14orf164 | Chromosome 14 open reading frame 164 | | | | | | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
GLYATL1 | Glycine-N-acyltransferase-like 1 | Enzymes Mitochondrial proteins
| | | | | Group enriched |
PIPOX | Pipecolic acid oxidase | Enzymes Plasma proteins
| | | | | Group enriched |
TFAP2B | Transcription factor AP-2 beta (activating enhancer binding protein 2 beta) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
AP000322.53 | | Predicted membrane proteins
| | | | | Group enriched |
LINC00955 | Long intergenic non-protein coding RNA 955 | Predicted membrane proteins
| | | | | Group enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
TREH | Trehalase (brush-border membrane glycoprotein) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
CLDN14 | Claudin 14 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Group enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | | | | Group enriched |
KRTAP5-8 | Keratin associated protein 5-8 | | | | | | Group enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | | | | Group enriched |
ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | Enzymes
| | | | | Group enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CLEC18A | C-type lectin domain family 18, member A | Predicted secreted proteins
| | | | | Group enriched |
FAM151A | Family with sequence similarity 151, member A | | | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
CLEC18B | C-type lectin domain family 18, member B | Predicted secreted proteins
| | | | | Group enriched |
HRSP12 | Heat-responsive protein 12 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
NKAIN4 | Na+/K+ transporting ATPase interacting 4 | Predicted membrane proteins
| | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
RIPPLY1 | Ripply transcriptional repressor 1 | Predicted secreted proteins
| | | | | Group enriched |
SPP1 | Secreted phosphoprotein 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
DLGAP2 | Discs, large (Drosophila) homolog-associated protein 2 | Nuclear receptors
| | | | | Group enriched |
FRMD7 | FERM domain containing 7 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
UGT2B7 | UDP glucuronosyltransferase 2 family, polypeptide B7 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
GLYAT | Glycine-N-acyltransferase | Enzymes Mitochondrial proteins
| | | | | Group enriched |
LPPR1 | Lipid phosphate phosphatase-related protein type 1 | Predicted membrane proteins
| | | | | Group enriched |
MYOM3 | Myomesin 3 | | | | | | Group enriched |
PAX2 | Paired box 2 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Group enriched |
SLC47A2 | Solute carrier family 47 (multidrug and toxin extrusion), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ACOT6 | Acyl-CoA thioesterase 6 | | | | | | Group enriched |
CLCNKB | Chloride channel, voltage-sensitive Kb | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
DUSP15 | Dual specificity phosphatase 15 | Enzymes
| | | | | Group enriched |